Endofin, a novel BMP-SMAD regulator of the iron-regulatory hormone, hepcidin

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Goh, Justin B ^a,b   Wallace, Daniel F ^a,b   Hong, Wanjin ^a   Subramaniam, V Nathan ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 6; HEPCIDIN; IRON; PROTEIN BINDING; SERINE PROTEINASE; SIGNAL PEPTIDE; SMAD PROTEIN; SMAD1 PROTEIN; ZFYVE16 PROTEIN, HUMAN;

BIOLOGICAL MODEL; CELL LINE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC POLYMORPHISM; GENETICS; HUMAN; METABOLISM; MUTATION; PHOSPHORYLATION; PROTEIN TRANSPORT;

BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEINS; CELL LINE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; HEPCIDINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; MODELS, BIOLOGICAL; MUTATION; PHOSPHORYLATION; POLYMORPHISM, GENETIC; PROTEIN BINDING; PROTEIN TRANSPORT; SERINE ENDOPEPTIDASES; SMAD PROTEINS; SMAD1 PROTEIN;

EID: 84941588340     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep13986     Document Type: Article

References (43)

1. Paralkar, V. M., Vukicevic, S. & Reddi, A. H. Transforming growth factor beta type 1 binds to collagen IV of basement membrane matrix: implications for development. Dev Biol 143, 303-308 (1991).
2. Tian, H. Y. et al. Comparative proteomic analysis of cell cycle-dependent apoptosis induced by transforming growth factor-beta. Biochim Biophys Acta 1794, 1387-1397 (2009).
3. Miyazono, K., Kamiya, Y. & Morikawa, M. Bone morphogenetic protein receptors and signal transduction. J Biochem 147, 35-51 (2010).
4. Derynck, R. & Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584 (2003).
5. Rosenzweig, B. L. et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92, 7632-7636 (1995).
6. Cheifetz, S., Like, B. & Massague, J. Cellular distribution of type I and type II receptors for transforming growth factor-beta. J Biol Chem 261, 9972-9978 (1986).
7. Canalis, E., Economides, A. N. & Gazzerro, E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocrine reviews 24, 218-235 (2003).
8. Kim, J., Johnson, K., Chen, H. J., Carroll, S. & Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308 (1997).
9. Yamamoto, N. et al. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238, 574-580 (1997).
10. Zhang, Y., Feng, X., We, R. & Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383, 168-172 (1996).
11. Zhang, Y., Musci, T. & Derynck, R. The tumor suppressor Smad4 DPC 4 as a central mediator of Smad function. Curr Biol 7, 270-276 (1997).
12. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L. & Wrana, J. L. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95, 779-791 (1998).
13. Shi, W. et al. Endofin acts as a Smad anchor for receptor activation in BMP signaling. J Cell Sci 120, 1216-1224 (2007).
14. Seet, L. F. & Hong, W. Endofin, an endosomal FYVE domain protein. J Biol Chem 276, 42445-42454 (2001).
15. Stenmark, H., Aasland, R., Toh, B. H. & DArrigo, A. Endosomal localization of the autoantigen EEA1 is mediated by a zincbinding FYVE finger. J Biol Chem 271, 24048-24054 (1996).
16. Gillooly, D. J., Simonsen, A. & Stenmark, H. Cellular functions of phosphatidylinositol 3-phosphate and FYVE domain proteins. Biochem J 355, 249-258 (2001).
17. Mills, I. G., Urbe, S. & Clague, M. J. Relationships between EEA1 binding partners and their role in endosome fusion. J Cell Sci 114, 1959-1965 (2001).
18. Ryan, J. D., Ryan, E., Fabre, A., Lawless, M. W. & Crowe, J. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology 52, 1266-1273 (2010).
19. Gehrke, S. G. et al. Iron stores modulate hepatic hepcidin expression by an HFE-independent pathway. Digestion 72, 25-32 (2005).
20. Katagiri, T. et al. Identification of a BMP-responsive element in Id1, the gene for inhibition of myogenesis. Genes Cells 7, 949-960 (2002).
21. Benchabane, H. & Wrana, J. L. GATA- and Smad1-dependent enhancers in the Smad7 gene differentially interpret bone morphogenetic protein concentrations. Mol Cell Biol 23, 6646-6661 (2003).
22. Lee, P. L., Beutler, E., Rao, S. V. & Barton, J. C. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 103, 4669-4671 (2004).
23. Babitt, J. L. et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 117, 1933-1939 (2007).
24. Toy, W., Lim, S. K., Loh, M. C. & Lim, Y. P. EGF-induced tyrosine phosphorylation of Endofin is dependent on PI3K activity and proper localization to endosomes. Cell Signal 22, 437-446 (2010).
25. Meynard, D. et al. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 41, 478-481 (2009).
26. Andriopoulos, B., Jr. et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 41, 482-487 (2009).
27. Babitt, J. L. et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38, 531-539 (2006).
28. Goto, D. et al. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3- mediated signaling. Biochem Biophys Res Commun 281, 1100-1105 (2001).
29. Bakkebo, M. et al. SARA is dispensable for functional TGF-beta signaling. FEBS Lett 586, 3367-3372 (2012).
30. Zhang, F. et al. Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res 24, 1224-1233 (2009).
31. Miura, S. et al. Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol 20, 9346-9355 (2000).
32. Chen, Y. G., Wang, Z., Ma, J., Zhang, L. & Lu, Z. Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-beta signaling. J Biol Chem 282, 9688-9695 (2007).
33. Zuo, X. et al. Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nature communications 6, 6793 (2015).
34. Zhang, Y. et al. Transforming growth factor-beta1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. Clin Exp Pharmacol Physiol 41, 921-932 (2014).
35. Chambers, J. C. et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels. Nat Genet 41, 1170-1172 (2009).
36. Benyamin, B. et al. Common variants in TMPRSS6 are associated with iron status and erythrocyte volume. Nat Genet 41, 1173-1175 (2009).
37. Chen, Y. et al. Phosphoproteomics identified Endofin, DCBLD2, and KIAA0582 as novel tyrosine phosphorylation targets of EGF signaling and Iressa in human cancer cells. Proteomics 7, 2384-2397 (2007).
38. McDonald, C. J. et al. Increased iron stores correlate with worse disease outcomes in a mouse model of schistosomiasis infection. PLoS One 5, e9594 (2010).
39. Rishi, G., Crampton, E. M., Wallace, D. F. & Subramaniam, V. N. In situ proximity ligation assays indicate that hemochromatosis proteins Hfe and transferrin receptor 2 (Tfr2) do not interact. PLoS One 8, e77267 (2013).
40. Wallace, D. F., McDonald, C. J., Ostini, L. & Subramaniam, V. N. Blunted hepcidin response to inflammation in the absence of Hfe and transferrin receptor 2. Blood 117, 2960-2966 (2011).
41. Scott, S. P., Teh, A., Peng, C. & Lavin, M. F. One-step site-directed mutagenesis of ATM cDNA in large (20kb) plasmid constructs. Hum Mutat 20, 323 (2002).
42. Wallace, D. F., Harris, J. M. & Subramaniam, V. N. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype. Am J Physiol Cell Physiol 298, C75-84 (2010).
43. Oliver, J. D., van der Wal, F. J., Bulleid, N. J. & High, S. Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275, 86-88 (1997).